Methadone Use in Hepatocellular Carcinoma Patients

Key Hepatic Function Parameters to Assess

Prothrombin time (PT/INR) reflects synthetic liver function and coagulation capacity, and should be assessed in patients with hepatic disease, according to the American College of Gastroenterology 1, 2, 3
Albumin indicates hepatic synthetic function and protein-binding capacity, and should be evaluated in patients with liver disease, as recommended by the American Association for the Study of Liver Diseases 1, 2, 3
Bilirubin measures hepatic excretory function and degree of liver dysfunction, and should be monitored in patients with hepatocellular carcinoma, according to the National Comprehensive Cancer Network 1, 2, 3

Fentanyl is the safest first-line choice for pain management in HCC patients with cirrhosis, as its disposition remains largely unaffected by hepatic impairment, according to the European Association for the Study of the Liver 5
Hydromorphone represents another safer alternative with relatively stable half-life in liver dysfunction, as recommended by the American Pain Society 5, 4

Child-Pugh Class C cirrhosis (indicated by bilirubin >3 mg/dL, albumin <2.8 g/dL, PT >6 seconds prolonged, plus ascites and encephalopathy) warrants avoiding methadone, according to the American Association for the Study of Liver Diseases 5
Significantly elevated bilirubin suggesting decompensated liver disease requires extreme caution when using methadone, as recommended by the National Comprehensive Cancer Network 1, 2, 3
Markedly prolonged PT/INR indicating severe synthetic dysfunction necessitates careful consideration of methadone use, according to the American College of Gastroenterology 1, 2, 3
Severe hypoalbuminemia (<2.5 g/dL) increases free drug fraction and requires dose adjustment, as recommended by the European Association for the Study of the Liver 1, 2, 3

Starting with 50% of the standard dose in patients with liver failure is recommended, according to the American Pain Society 4
Monitoring closely for hepatic encephalopathy is necessary, as opioids are a major precipitant, as recommended by the American Association for the Study of Liver Diseases 5, 4
Assessing renal function concurrently is crucial, as hepatorenal syndrome may further impair drug clearance, according to the National Kidney Foundation 4